Sonnenberg P, Murray J, Glynn J R, Shearer S, Kambashi B, Godfrey-Faussett P
Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Lancet. 2001 Nov 17;358(9294):1687-93. doi: 10.1016/S0140-6736(01)06712-5.
The proportion of recurrent tuberculosis cases attributable to relapse or reinfection and the risk factors associated with these different mechanisms are poorly understood. We followed up a cohort of 326 South African mineworkers, who had successfully completed treatment for pulmonary tuberculosis in 1995, to determine the rate and mechanisms of recurrence.
Patients were examined 3 and 6 months after cure, and then were monitored by the routine tuberculosis surveillance system until December, 1998. IS6110 DNA fingerprints from initial and subsequent episodes of tuberculosis were compared to determine whether recurrence was due to relapse or reinfection All patients gave consent for HIV-1 testing.
During follow-up (median 25.1 months, IQR 13.2-33.4), 65 patients (20%) had a recurrent episode of tuberculosis, a recurrence rate of 10.3 episodes per 100 person-years at risk (PYAR)-16.0 per 100 pyar in HIV-1-positive patients and 6.4 per 100 pyar in HIV-1-negative patients. Paired DNA fingerprints were available in 39 of 65 recurrences: 25 pairs were identical (relapse) and 14 were different (reinfection). 93% (13/14) of recurrences within the first 6 months were attributable to relapse compared with 48% (12/25) of later recurrences. HIV-1 infection was a risk factor for recurrence (hazard ratio 2.4, 95% CI 1.5-4.0), due to its strong association with disease caused by reinfection (18.7 2.4-143), but not relapse (0.58; 0.24-1.4). Residual cavitation and increasing years of employment at the mine were risk factors for relapse.
In a setting with a high risk of tuberculous infection, HIV-1 increases the risk of recurrent tuberculosis because of an increased risk of reinfection. Interventions to prevent recurrent disease, such as lifelong chemoprophylaxis in HIV-1-positive tuberculosis patients, should be further assessed.
因复发或再感染导致的复发性结核病病例比例以及与这些不同机制相关的危险因素尚未完全明确。我们对一组326名南非矿工进行了随访,这些矿工在1995年成功完成了肺结核治疗,以确定复发率和复发机制。
患者在治愈后3个月和6个月接受检查,然后由常规结核病监测系统进行监测,直至1998年12月。比较初次及后续结核病发作时的IS6110 DNA指纹图谱,以确定复发是由于复发还是再感染。所有患者均同意进行HIV-1检测。
在随访期间(中位时间25.1个月,四分位间距13.2 - 33.4个月),65名患者(20%)出现了结核病复发,复发率为每100人年风险期(PYAR)10.3次发作 - HIV-1阳性患者为每100 PYAR 16.0次发作,HIV-1阴性患者为每100 PYAR 6.4次发作。65例复发中有39例获得了配对的DNA指纹图谱:25对相同(复发),14对不同(再感染)。在前6个月内复发的病例中,93%(13/14)归因于复发,而后期复发的病例中这一比例为48%(12/25)。HIV-1感染是复发的危险因素(风险比2.4,95%置信区间1.5 - 4.0),这是因为它与再感染导致的疾病密切相关(18.7;2.4 - 143),但与复发无关(0.58;0.24 - 1.4)。残留空洞和在矿山工作年限增加是复发的危险因素。
在结核感染风险较高的环境中,HIV-1会因再感染风险增加而提高复发性结核病的风险。应进一步评估预防复发性疾病的干预措施,如对HIV-1阳性结核病患者进行终身化学预防。